1H-Pyrazole-5-carboxamide, 4-(5-chloro-2-furanyl)-1,3-bis(2,4-difluorophenyl)-4,5-dihydro-5-methyl-N-[(4-methyl-2-morpholinyl)methyl]
|
|
2171015-78-2
|
15-Keto prostaglandin E2
|
|
26441-05-4
|
1-Octadecyl lysophosphatidic acid
|
|
52977-29-4
|
17(R)-HETE
|
|
183509-24-2
|
15-Lipoxygenase Inhibitor 1
|
|
928853-86-5
|
17-Oxo-4(Z),7(Z),10(Z),13(Z),15(E),19(Z)-docosahexaenoic acid
|
|
1233715-28-0
|
15-Cyclohexyl pentanor prostaglandin F2α
|
|
58611-97-5
|
2-(3-Pyrazolyl)ethanamine Dihydrochloride
|
|
138-92-1
|
1-Cyclohexyl-3-dodecyl urea
|
|
402939-18-8
|
1-Phenylpyrrole
|
|
635-90-5
|
15(S)-HpETE
|
|
70981-96-3
|
1H-Pyrrolo[2,1-c][1,2,4]benzothiadiazine, 2,3,3a,4-tetrahydro-, 5,5-dioxide, (3aR)-
|
|
175340-21-3
|
2-(2-Pyridyl)ethylamine
|
|
2706-56-1
|
2-(4-(Piperidin-3-yl)phenyl)-2H-indazole-7-carboxamide
|
|
1038915-75-1
|
2-(p-Chlorophenoxy)-2-methylpropionic acid
|
|
882-09-7
|
2,4-DPD
|
|
41438-38-4
|
16(S)-Iloprost
|
|
74843-14-4
|
16-Phenoxy tetranor prostaglandin F2α methyl ester
|
|
51638-90-5
|
1-Octadecyl lysophosphatidic acid sodium salt
|
|
|
17-Oxo-7(Z),10(Z),13(Z),15(E),19(Z)-docosapentaenoic acid
|
|
1233715-33-7
|
15(R)-Prostaglandin D2
|
|
59894-05-2
|
2,3-Butanedione-2-monoxime
|
|
57-71-6
|
2-(5,7-Dichloro-1H-indol-3-yl)ethan-1-amine
|
|
2447-23-6
|
2,2-Diphenylethyl isothiocyanate
|
|
34634-22-5
|
16,16-Dimethyl prostaglandin A2
|
|
41691-92-3
|
2-((2,2-Dibenzylhydrazineylidene)methyl)pyridine
|
|
237402-29-8
|
1-Palmitoyl lysophosphatidic acid
|
|
22002-85-3
|
1-Benzyl-4-cyano-4-phenylpiperidine
|
|
56243-25-5
|
1H-3-Benzazepine-7,8-diol,6-chloro-2,3,4,5-tetrahydro-1-phenyl-3-(2-propen-1-yl)-, hydrobromide (1:1)
|
|
74115-01-8
|
16-Epi latrunculin B
|
|
444911-05-1
|
1H-1,2,3-Triazole
|
|
288-36-8
|
16:0 Lyso PA (sodium salt)
|
|
17618-08-5
|
17-Trifluoromethylphenyl trinor prostaglandin F2α
|
|
221246-34-0
|
1-methyl-tryptophan
|
|
26988-72-7
|
2-(1-Benzyl-1H-indazol-3-yloxy)acetic Acid
|
|
20187-55-7
|
2-(5-fluoropentyl)-2-methylmalonic acid
|
|
1216897-16-3
|
1-Azetidinecarboxamide, 3-(1-methylethoxy)-N-[[2-methyl-4-[2-[(1-methyl-1H-pyrazol-4-yl)amino]-4-pyrimidinyl]phenyl]methyl]-
|
|
1798787-27-5
|
17(S)-HETE
|
|
183509-25-3
|
16-Phenoxy prostaglandin F2α ethyl amide
|
|
951319-59-8
|
16-Phenyl tetranor prostaglandin F2α
|
|
38315-48-9
|
1-Oleoyl lysophosphatidic acid
|
|
65528-98-5
|
17β-Hydroxy wortmannin
|
|
58053-83-1
|
1-Phenylbiguanide
|
|
102-02-3
|
17-Phenoxy trinor prostaglandin F2α
|
|
|
1-Benzyl-4-cyano-4-phenylpiperidine hydrochloride
|
|
71258-18-9
|
16(R)-AFP 07
|
|
773825-80-2
|
2,3-Dihydroxy-4-methoxybenzaldehyde
|
|
4055-69-0
|
2,4-Dihydroxyphenylacetyl-L-asparagine
|
|
111872-98-1
|
17-Phenyl trinor prostaglandin F2α 1,15-lactone
|
|
|
1-EBIO
|
|
10045-45-1
|
2-((2-Nitrophenyl)thio)ethanohydrazide
|
|
4871-40-3
|
2,2,2-Trichloroethanol
|
|
115-20-8
|
2,3-Pyridinedicarboxylic acid
|
|
89-00-9
|
2,4-Dichlorophenoxyacetic acid sodium salt
|
|
2702-72-9
|
2,3-Dihydrothieno-thiadiazole carboxylate
|
|
152467-47-5
|
2-(Oxalylamino)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxylic acid
|
|
243967-42-2
|
1α, 24, 25-Trihydroxy VD2
|
|
457048-34-9
|
15(S)-HEPE
|
|
86282-92-0
|
1-Stearoyl-2-Arachidonoyl-sn-glycerol
|
|
65914-84-3
|
15(R)-17-Phenyl trinor prostaglandin F2α
|
|
41639-71-8
|
1-Phenylsemicarbazide
|
|
103-03-7
|
16(R)-Iloprost
|
|
74843-13-3
|
2-(4-(4-Chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetamide
|
|
202591-23-9
|
2,4-DMA hydrochloride
|
|
33189-36-5
|
16,16-Dimethyl Prostaglandin E2
|
|
39746-25-3
|
16-Phenoxy tetranor prostaglandin F2α methyl amide
|
|
|
15-deoxy-Δ12,14-prostaglandin J2-2-glycerol ester
|
|
|
1-Amino-8-naphthol-2,4-disulfonic acid
|
|
82-47-3
|
1e,3e,5a-Triphenylcyclohexane
|
|
|
16,16-Dimethyl prostaglandin F2α
|
|
39746-23-1
|
1-Methyl-2-[(4Z,7Z)-4,7-tridecadienyl]-4(1H)-quinolone
|
|
120693-53-0
|
1-Naphthyl 3,5-dinitrobenzoate
|
|
93261-39-3
|
1-Palmitoyl-d9-2-Palmitoyl-sn-glycerol
|
|
1872379-48-0
|
16-Phenoxy tetranor prostaglandin F2α isopropyl ester
|
|
130209-78-8
|
15-keto-17-phenyl trinor prostaglandin F2α
|
|
949564-89-0
|
1-Hexadecyl lysophosphatidic acid
|
|
52603-03-9
|
19(R)-Hydroxy prostaglandin E1
|
|
64625-55-4
|
19(R)-Hydroxy prostaglandin E2
|
|
64625-54-3
|
1-Methyl-2-[(6Z,9Z)-6,9-pentadecadienyl]-4(1H)-quinolone
|
|
120693-52-9
|
15-Methyl PGE2 methyl ester
|
|
36210-00-1
|
1a-Phenyl-4e-(1'-phenylethyl)tetralin
|
|
|
1-Pentalenol, 5-hexyl-1,2,3,3a,6,6a-hexahydro-4-phenyl-3a-(1-phenylethenyl)-, (1R,3aS,6aS)-rel-
|
|
1276664-61-9
|
1-Ethyl-6-fluoro-4-oxo-7-(4-(3-phenylpropanoyl)piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid
|
|
924198-81-2
|
15(S)-Fluprostenol
|
|
54276-24-3
|
1e-Phenyl-4a-(1'-phenylethyl)tetralin
|
|
|
15(R)-Prostaglandin E1
|
|
20897-91-0
|
1-Aminodecylidene bis-phosphonic acid sodium salt
|
|
|
2-(Pentylsulfanyl)pyrimidine-4,6-diol
|
|
489403-70-5
|
17-AAG hydrochloride
|
|
911710-03-7
|
1-Hexadecyl lysophosphatidic acid sodium salt
|
|
|
17-Phenyl trinor prostaglandin E2 ethyl amide
|
|
1219032-20-8
|
16,17-Dihydroheronamide C
|
|
2698333-36-5
|
15-LOX-1 inhibitor i472
|
|
2349374-37-2
|
1-Benzyl-2-ethyl-4,5,6,7-tetrahydro-1H-indol-4-one
|
|
218934-50-0
|
2-(E-2-decenoylamino)ethyl 2-(cyclohexylethyl) sulfide
|
|
137089-36-2
|
2,4,6-Tribromophenyl caproate
|
|
16732-09-5
|
16(R)-HETE
|
|
183509-22-0
|
1a-Phenyl-4a-(1'-phenylethyl)tetralin
|
|
|
2-(2-((3aS,4S,5R,6aS,E)-5-Hydroxy-4-((3S,4R)-3-hydroxy-4-methylnona-1,6-diyn-1-yl)hexahydropentalen-2(1H)-ylidene)ethoxy)acetic acid
|
|
95722-07-9
|
1-Naphthyl phosphate potassium salt
|
|
100929-85-9
|